JSPR Jasper Therapeutics, Inc.
$0.66▼ -5.77%
Healthcare
Other
After hours
$0.66▼ -0.03%
Sep 11, 7:30 PM ET
Volume 284.5K
Avg Volume (10D) 339.9K
Key Metrics & Fundamentals
Market Cap
$21.97M
P/E Ratio
–
Div Yield
–%
52W Range
0.32 - 2.69
% vs 50 MA
-4.90%
% vs 200 MA
-37.82%
RSI-14
42.8
MACD Histogram
-0.0100
Beta (1Y vs SPY)
1.71
Free Cash Flow
-$6.92M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$13.17M
COGS
–
Operating Exp
$9.21M
Operating Income
-$9.21M
EBIT
-$9.21M
Pretax Income
-$2.76M
Net Income
-$2.76M
EPS (Diluted)
-0.10
Price & Volume History
Loading chart…
Recent News

Jasper Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference
GlobeNewswire · Sep 9, 2026 12:00 PM

Jasper Therapeutics beats Q2 expectations but shares fall after results
InvestorsHub · Aug 17, 2026 12:30 PM

Jasper Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
GlobeNewswire · Aug 14, 2026 3:00 PM
Piper Sandler Initiates Jasper Therapeutics With Overweight Rating, $2 Price Target
MT Newswires · Aug 12, 2026 10:52 AM
Jasper gets a lifeline in merger with immune drugmaker Kira
BioPharma Dive · Jul 17, 2026 11:54 AM
Jasper Therapeutics Completes Merger With Kira Pharmaceuticals, Shares Fall
MT Newswires · Jul 16, 2026 9:42 PM
Jasper Therapeutics Announces Merger with Kira Pharmaceuticals
GlobeNewswire · Jul 16, 2026 9:15 PM
Chronic Spontaneous Urticaria Market Heats Up as Pharma Companies Race to Address Unmet Needs | DelveInsight
PR Newswire · Jun 24, 2026 2:31 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See JSPR's money flow as a full page
Social Sentiment
No Reddit posts found for JSPR.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.